Thierry Chauche serves as Chief Financial Officer at Sagimet Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Thierry Chauche has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2026 involved receiving (via award) 88,000 shares valued at $0.
Thierry Chauche currently holds 88,000 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Thierry Chauche has been a net neutral trader of SGMT stock. They have purchased $0 and sold $0 worth of shares.
Thierry Chauche's most recent insider trade was on Feb 19, 2026, when they sold 88,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |